Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
According to findings shared by Diabetes in Control, these medications are becoming central to cardiometabolic care
* Maintain heart health and improve heart quality
In the Lira Pump study, they decreased basal insulin by 10%, but increased bolus by 15% ( Our current practice is to consider a ~20% bolus insulin decrease and a ~10% basal insulin decrease before GLP-1RA initiation, although prior A1c, risk of hypoglycemia, potential risk of ketosis due to reduced insulin doses, as well as other patient-specific factors should guide the final insulin dose changes
Most guidelines recommend discarding after twenty-four to forty-eight hours
Key Takeaway: Combining Ozempic and tirzepatide is redundant because they both target the same GLP-1 receptors
US$ 21.18
US$ 21.26
US$ 27.62
US$ 23.83
US$ 21.83
US$ 27.74
US$ 26.26
US$ 23.41
